Cancer Type Guide

Lung Cancer

Lung cancer is one of the most common and deadliest types of cancer worldwide. It develops when abnormal cells in the lungs grow uncontrollably, forming tumors that interfere with normal lung function.
Book a Free Consultation
UNDERSTANDING LUNG CANCER

What is Lung Cancer?

Lung cancer is one of the most common and deadliest types of cancer worldwide. It develops when abnormal cells in the lungs grow uncontrollably, forming tumors that interfere with normal lung function. If left untreated, these cancer cells can spread to nearby lymph nodes and distant organs such as the brain, liver, bones, or adrenal glands.

There are two main types of lung cancer: Non-Small Cell Lung Cancer (NSCLC), which accounts for approximately 85% of cases, and Small Cell Lung Cancer (SCLC), a more aggressive form that tends to spread rapidly. Smoking remains the leading risk factor, but lung cancer can also occur in non-smokers due to genetic factors, air pollution, radon exposure, secondhand smoke, or occupational exposure to harmful substances.

Early detection plays a crucial role in improving treatment outcomes, as lung cancer often develops without noticeable symptoms in its initial stages.

PRECISE CANCER ASSESSMENT

Comprehensive Lung Cancer Diagnosis

Diagnosing lung cancer involves several tests to confirm the presence of cancer and determine its stage. These may include:

  • Physical examination and medical history
  • Chest X-ray
  • Computed Tomography (CT) scan
  • Positron Emission Tomography (PET-CT)
  • Magnetic Resonance Imaging (MRI)
  • Bronchoscopy
  • Needle biopsy or surgical biopsy
  • Sputum cytology
  • Molecular and genetic testing

Once cancer is confirmed, staging is performed to determine the size of the tumor, lymph node involvement, and whether the disease has metastasized.

Accurate staging enables specialists to develop the most appropriate and personalised treatment plan.

RECOGNISE THE WARNING SIGNS

Common Symptoms of Lung Cancer

Lung cancer symptoms often do not appear until the disease has progressed. However, common warning signs include:

  • A persistent cough that does not improve or becomes worse
  • Coughing up blood or blood-stained mucus
  • Chest pain that worsens with deep breathing or coughing
  • Shortness of breath or difficulty breathing
  • Wheezing
  • Hoarseness or changes in voice
  • Recurrent lung infections such as pneumonia or bronchitis
  • Unexplained weight loss
  • Loss of appetite
  • Persistent fatigue or weakness

When lung cancer spreads to other parts of the body, additional symptoms may develop, including:

  • Bone pain
  • Headaches
  • Dizziness
  • Swelling of the face or neck
  • Neurological symptoms caused by brain metastases

Because many of these symptoms can also be caused by non-cancerous conditions, medical evaluation is essential for an accurate diagnosis.

Advanced Technologies

Minimally Invasive Treatment Options

Modern Cancer Hospital Guangzhou specialises in minimally invasive cancer treatments that precisely target tumours while minimising damage to healthy tissue.

Depending on each patient’s condition, therapies such as interventional treatment, cryotherapy, microwave ablation, radioactive seed implantation, and other advanced techniques may be combined into a personalised treatment plan designed by a multidisciplinary team (MDT).

This approach aims to maximise treatment effectiveness while improving recovery and quality of life.

Surgery

Surgery is often recommended for early-stage Non-Small Cell Lung Cancer (NSCLC) when the tumour can be completely removed. Procedures may include wedge resection, lobectomy, or pneumonectomy, depending on the extent of the disease.

Chemotherapy

Chemotherapy uses anti-cancer drugs to destroy rapidly dividing cancer cells. It may be administered before surgery, after surgery, or as the primary treatment for advanced-stage lung cancer.

Radiation Therapy

Radiation therapy uses high-energy rays to destroy cancer cells. It can be used alone or in combination with surgery and chemotherapy to improve treatment outcomes.

Targeted Therapy

Patients with specific genetic mutations, such as EGFR, ALK, or ROS1, may benefit from targeted therapy, which attacks cancer cells while reducing damage to surrounding healthy tissue.

Immunotherapy

Immunotherapy enhances the body's immune system to identify and eliminate cancer cells. It has become an important treatment option for many patients with advanced lung cancer.

Get a Free Consultation

Our specialists are ready to review your case and design a personalised treatment plan.
Book Free Consultation
Get Started Today

Ready to Begin Your Treatment Journey?

Our patient coordinators are available 24/7 to review your diagnosis, explain which technologies apply, and arrange a free multidisciplinary case review.
Book a Free Consultation

Prof. Song Shijun

Chief Expert of the Oncology Department
Chief Physician • Professor

Introduction

Prof. Song Shijun is a professor, chief physician, and CPC member with over 40 years of clinical experience in oncology. He specializes in chemotherapy, minimally invasive therapy, biotherapy, and targeted therapy for various solid tumors.

Medical Experience

  • Over 40 years of clinical oncology experience.
  • Chief Expert of the Oncology Department and leader of the Multidisciplinary Team (MDT).
  • Specialized in chemotherapy, minimally invasive therapy, targeted therapy, biotherapy, and integrated cancer treatment.
  • Extensive experience in treating complex and advanced-stage malignant tumors.
  • Pioneer in integrating minimally invasive treatment with immunotherapy and precision medicine.
  • Has successfully treated more than 10,000 cancer patients, with many achieving long-term survival exceeding 10 years.
  • Frequently participates in international oncology conferences and promotes medical collaboration across Southeast Asia.

Research Areas

  • Precision Oncology
  • Minimally Invasive Cancer Therapy
  • Targeted Therapy
  • Biotherapy and Immunotherapy
  • Multidisciplinary Team (MDT) Cancer Management
  • Radiofrequency Ablation (RFA)
  • Palliative Care for Advanced Cancer
  • Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
  • Molecular Biomarkers in Cancer
  • Personalized Cancer Treatment Strategies
Book Consultation

Prof. Dai Wenyan

Director of Oncology Department · Director of Breast Cancer Center
Chief Physician

Introduction

Dr. Ma Xiaoying is a renowned oncologist with over 20 years of clinical experience. Specializing in precision minimally invasive therapy, she has treated more than 5,000 international patients, focusing on improving the quality of life and survival rates for advanced-stage cancer patients.

Medical Experience

  • Over 20 years of clinical work in oncology and cancer research.
  • Expertise in multidisciplinary (MDT) consultation and personalized treatment planning.
  • Completed advanced studies at the National University of Singapore (2015) and Sun Yat-sen University Cancer Center (2017 & 2019).
  • Specialist in minimally invasive techniques including interventional therapy, seed implantation, and cryotherapy.

Research Areas

  • Precision minimally invasive cancer treatment technologies.
  • Combination of targeted therapy, immunotherapy, and chemotherapy for refractory tumors.
  • Endoscopic diagnosis and treatment of malignant tumors.
  • Integrated medical models for advanced-stage cancer management.
Book Consultation

Ma Xiaoying

Director of Oncology Department
Associate Chief Physician

Introduction

Dr. Ma Xiaoying is a renowned oncologist with over 20 years of clinical experience. She specializes in minimally invasive precision treatments, combining targeted therapy and immunotherapy to provide individualized plans for advanced cancer patients, focusing on improving their quality of life.

Medical Experience

  • More than 20 years of extensive clinical work in the field of oncology.
  • Expertise in treating advanced and refractory tumors with rich clinical results.
  • Successfully treated over 5,000 international patients, particularly from Southeast Asia.
  • Proficient in implementing multidisciplinary (MDT) treatment plans and managing cancer complications.

Research Areas

  • Integration of minimally invasive technologies (interventional therapy, cryotherapy, microwave ablation) with molecular targeted therapy.
  • Individualized and comprehensive treatment protocols for solid tumors.
  • Advanced techniques in tumor endoscopy for both diagnosis and treatment.
  • Research on biological immunotherapy and endocrine therapy for late-stage cancers.
Book Consultation

Dr. Wang Baoli

Oncology Specialist
Associate Chief Physician

Introduction

Nearly 20 years of clinical oncology experience in China's top-tier Grade A tertiary hospitals. Expert in minimally invasive interventional therapy, chemotherapy, and combined targeted-immunotherapy, focusing on complex cancers and advocating a Multidisciplinary Team (MDT) treatment approach.

Medical Experience

  • Member, Hepatobiliary and Pancreatic Tumors Professional Committee, Guangzhou Anti-Cancer Association
  • Member, Tumor Immunotherapy Professional Committee, Guangdong Pharmaceutical Association
  • Member, Interventional Medicine Professional Committee, Guangzhou Medical Association
  • Member, Liver Cancer Professional Committee, Tumor Rehabilitation Branch, Chinese Geriatrics Society
  • Member, Thyroid Nodule and Tumor Prevention and Control Professional Committee, China Health Care Association
  • Published 5 papers in core medical journals and 1 SCI-indexed paper
  • Awarded 1 Third Prize for Military Medical Achievements
  • Participated in 1 provincial-level government-funded research project

Research Areas

  • Integrated minimally invasive therapy for tumors
  • Multidisciplinary Team (MDT) precision personalized diagnosis and treatment model
  • Application of combined targeted and immunotherapy strategies in oncology
Book Consultation

Lung Cancer

Introduction

Medical Experience

Research Areas

Book Consultation